The hard exudate pathway: Biological mechanisms, imaging correlates, and clinical implications

Hard exudates are common fundus findings in retinal vascular disease, but are frequently regarded as passive remnants of vascular leakage rather than biologically meaningful lesions. Traditionally described as lipid deposits associated with diabetic retinopathy and retinal vein occlusion, they have received limited integrative analysis across disease contexts. Emerging insights from vascular biology, lipid metabolism, and multimodal imaging challenge this view and reveal that hard exudates represent organized extracellular lipid-protein aggregates arising from sustained vascular-metabolic dysfunction. We synthesize current evidence on the biochemical composition, pathophysiology, and biophysical behavior of hard exudates, integrating contributions from both retinal and choroidal vascular compartments and dysfunction of the inner and outer blood-retinal barriers. Advances in optical coherence tomography enable precise layer-specific localization, facilitate differentiation from phenotypic mimickers, and support a mechanism-based diagnostic framework. Therapeutic considerations emphasize vascular stabilization over lesion-directed treatment, recognizing delayed and incomplete regression. Finally, emerging quantitative imaging and artificial intelligence-based approaches are discussed as future strategies to reposition hard exudates as dynamic biomarkers of disease chronicity and prognostic risk.